Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Lier Pharmaceutical Co., Ltd. is a specialized pharmaceutical company focused on the research, development, and large-scale production of pharmaceutical intermediates and active pharmaceutical ingredients (APIs). As a subsidiary of Lier Chemical Co., Ltd., the company utilizes advanced chemical synthesis technologies, particularly in chlorination and pyridine chemistry, to support the global drug supply chain. Their facilities are designed to meet stringent regulatory requirements, providing contract manufacturing services to major pharmaceutical firms. The company's portfolio primarily supports the production of anti-infective and cardiovascular medications. By leveraging the industrial scale and technical expertise of its parent company, Chengdu Lier has established itself as a reliable supplier of high-purity chemical building blocks.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 成都利尔药业.